Pharmacogenomics of neurodegenerative diseases

Author： Maimone D. Dominici R. Grimaldi L.M.E.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.413, Iss.1, 2001-02, pp. : 11-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics and pharmacogenetics of neurodegenerative diseases: towards new targets

By Amouyel Philippe

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Cholinergic receptors and neurodegenerative diseases

By Gualtieri F.

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite

Receptors in neurodegenerative diseases

By Froestl W.

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 247-251

Elsevier

Access to resources Recommend Favorite

Antioxidant strategies for neurodegenerative diseases

By Contestabile A.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 4, 2001-04 ,pp. : 573-585

Informa Healthcare

Access to resources Recommend Favorite